🐜
|
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
9 auth.
J. Kozlitina,
E. Smagris,
S. Stender,
B. Nordestgaard,
Heather H. Zhou,
A. Tybjærg‐Hansen,
...
T. Vogt,
H. Hobbs,
Jonathan C. Cohen
|
10 |
2014 |
10 🐜
|
🐜
|
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
133 auth.
D. Swerdlow,
D. Preiss,
Karoline B. Kuchenbaecker,
M. Holmes,
J. Engmann,
T. Shah,
R. Sofat,
S. Stender,
Paul C. D. Johnson,
R. Scott,
M. Leusink,
N. Verweij,
S. Sharp,
Yiran Guo,
C. Giambartolomei,
...
C. Chung,
A. Peasey,
A. Amuzu,
Kawah Li,
J. Palmen,
Philip N. Howard,
J. Cooper,
F. Drenos,
Yun R Li,
G. Lowe,
J. Gallacher,
Marlene C. W. Stewart,
I. Tzoulaki,
Sarah G Buxbaum,
D. van der A,
N. Forouhi,
N. Onland-Moret,
Y. T. van der Schouw,
R. Schnabel,
J. Hubacek,
R. Kubínová,
M. Baceviciene,
A. Tamošiūnas,
A. Pająk,
R. Topor-Madry,
U. Stepaniak,
S. Malyutina,
D. Baldassarre,
B. Sennblad,
E. Tremoli,
U. de Faire,
F. Veglia,
I. Ford,
J. Jukema,
R. Westendorp,
G. D. de Borst,
P. D. de Jong,
A. Algra,
W. Spiering,
Anke H Maitland-van der Zee,
O. Klungel,
A. de Boer,
P. Doevendans,
C. Eaton,
Jennifer G. Robinson,
D. Duggan,
J. Kjekshus,
J. Downs,
A. Gotto,
A. Keech,
R. Marchioli,
G. Tognoni,
P. Sever,
N. Poulter,
D. Waters,
T. Pedersen,
P. Amarenco,
H. Nakamura,
J. McMurray,
J. Lewsey,
D. Chasman,
P. Ridker,
A. Maggioni,
L. Tavazzi,
K. Ray,
S. Seshasai,
J. Manson,
J. Price,
P. Whincup,
R. Morris,
D. Lawlor,
G. Smith,
Y. Ben-Shlomo,
P. Schreiner,
M. Fornage,
D. Siscovick,
M. Cushman,
M. Kumari,
N. Wareham,
W. Verschuren,
S. Redline,
Sanjay R. Patel,
J. Whittaker,
A. Hamsten,
J. A. Delaney,
C. Dale,
Tom R. Gaunt,
A. Wong,
D. Kuh,
R. Hardy,
S. Kathiresan,
B. A. Castillo,
P. van der Harst,
E. Brunner,
A. Tybjaerg-hansen,
M. Marmot,
R. Krauss,
M. Tsai,
J. Coresh,
R. Hoogeveen,
B. Psaty,
L. Lange,
H. Hakonarson,
F. Dudbridge,
S. Humphries,
P. Talmud,
M. Kivimäki,
N. Timpson,
C. Langenberg,
F. Asselbergs,
M. Voevoda,
M. Bobák,
H. Pikhart,
James G. Wilson,
A. Reiner,
B. Keating,
A. Hingorani,
N. Sattar
|
9 |
2015 |
9 🐜
|
🐜
|
A Protein‐Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
48 auth.
N. Abul-Husn,
Xi-ping Cheng,
Alexander Hanbo Li,
Yurong Xin,
C. Schurmann,
P. Stevis,
Yashu Liu,
J. Kozlitina,
S. Stender,
C. Wood,
Ann N. Stepanchick,
Matthew D. Still,
S. McCarthy,
C. O’Dushlaine,
Jonathan S. Packer,
...
S. Balasubramanian,
Nehal Gosalia,
David M. Esopi,
Sun Y. Kim,
Semanti Mukherjee,
Alexander E. Lopez,
Erin D. Fuller,
John Penn,
Xin Chu,
Jonathan Z. Luo,
U. Mirshahi,
D. Carey,
C. Still,
M. Feldman,
Aeron M. Small,
S. Damrauer,
D. Rader,
B. Zambrowicz,
W. Olson,
A. Murphy,
I. Borecki,
A. Shuldiner,
J. Reid,
J. Overton,
G. Yancopoulos,
H. Hobbs,
Jonathan C. Cohen,
O. Gottesman,
Tanya M. Teslovich,
A. Baras,
T. Mirshahi,
J. Gromada,
F. Dewey
|
9 |
2018 |
9 🐜
|
🦁
|
Adiposity Amplifies the Genetic Risk of Fatty Liver Disease Conferred by Multiple Loci
S. Stender,
J. Kozlitina,
B. Nordestgaard,
A. Tybjærg‐Hansen,
H. Hobbs,
Jonathan C. Cohen
|
8 |
2017 |
8 🦁
|
🐜
|
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
21 auth.
P. Dongiovanni,
S. Stender,
A. Pietrelli,
R. Mancina,
A. Cespiati,
S. Petta,
S. Pelusi,
P. Pingitore,
S. Badiali,
M. Maggioni,
...
V. Mannisto,
S. Grimaudo,
R. Pipitone,
J. Pihlajamaki,
A. Craxì,
M. Taube,
L. Carlsson,
S. Fargion,
S. Romeo,
J. Kozlitina,
Luca Valenti
|
8 |
2017 |
8 🐜
|
🐜
|
Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals
7 auth.
B. Lauridsen,
S. Stender,
T. Kristensen,
K. Kofoed,
L. Køber,
B. Nordestgaard,
...
A. Tybjærg‐Hansen
|
7 |
2018 |
7 🐜
|
🐢
|
Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population
H. Gellert-Kristensen,
T. Richardson,
G. Davey Smith,
B. Nordestgaard,
A. Tybjaerg-hansen,
S. Stender
|
7 |
2020 |
7 🐢
|
🦁
|
Elevated body mass index as a causal risk factor for symptomatic gallstone disease: A Mendelian randomization study
S. Stender,
B. Nordestgaard,
A. Tybjærg‐Hansen
|
7 |
2013 |
7 🦁
|
🐬
|
Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study.
M. Benn,
A. Tybjærg‐Hansen,
S. Stender,
R. Frikke-Schmidt,
B. Nordestgaard
|
7 |
2011 |
7 🐬
|
🦁
|
Fast food: unfriendly and unhealthy
S. Stender,
J. Dyerberg,
Astrup Av
|
6 |
2007 |
6 🦁
|
🦁
|
Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta‐analysis
S. Stender,
R. Frikke-Schmidt,
B. Nordestgaard,
Peer Grande,
A. Tybjærg‐Hansen
|
6 |
2013 |
6 🦁
|